PCN123 BUDGET IMPACT ANALYSIS OF FIRST-LINE RIBOCICLIB IN THE TREATMENT OF PRE- AND POST-MENOPAUSAL WOMEN WITH HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER IN THE UNITED STATES
Zhou, J., Edwards, M.L., Fang, H., Oderda, G., Brixner, D., Biskupiak, J.E., Balu, S.Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.1613
Date:
May, 2020
File:
PDF, 318 KB
2020